U.S. markets open in 7 hours 12 minutes

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.07+0.91 (+6.43%)
At close: 04:00PM EDT
14.73 -0.34 (-2.26%)
After hours: 04:06PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close14.16
Bid0.00 x 1100
Ask0.00 x 1400
Day's Range13.92 - 15.26
52 Week Range11.70 - 49.23
Avg. Volume448,980
Market Cap400.506M
Beta (5Y Monthly)2.74
PE Ratio (TTM)N/A
EPS (TTM)-7.53
Earnings DateNov 07, 2022 - Nov 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est49.91
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for ARCT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Arcturus Therapeutics Holdings
    Daily – Vickers Top Buyers & Sellers for 08/13/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    last yearArgus Research
View more
  • Business Wire

    Arcturus Therapeutics to Attend the Following Investor Conferences

    SAN DIEGO, September 27, 2022--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global, late-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences.

  • InvestorPlace

    7 Small-Cap Stocks to Buy on the Dip or You’ll Be Kicking Yourself Later

    With several worrying developments domestically and internationally, many investors chose to rush for the exits, though a brave few may have opportunities in small-cap stocks to buy on the dip. Tethered to small-capitalization companies, these market ideas don’t always grab the spotlight. But when they do, their relatively diminutive profiles occasionally enable massive profitability. Effectively, small-cap stocks to buy are the equivalent of carrying small objects uphill rather than large ones.

  • Simply Wall St.

    Rock star Growth Puts Arcturus Therapeutics Holdings (NASDAQ:ARCT) In A Position To Use Debt

    Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...